416 related articles for article (PubMed ID: 19347274)
1. cDNA microarray analysis of inflammatory breast cancer signatures.
Laere SJ; Vermeulen PB; Dirix LY
Methods Mol Biol; 2009; 512():71-98. PubMed ID: 19347274
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
[TBL] [Abstract][Full Text] [Related]
3. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S; Van der Auwera I; Van den Eynden GG; Fox SB; Bianchi F; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2005 Oct; 93(3):237-46. PubMed ID: 16172796
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil.
Behera RK; Nayak R
Cancer Invest; 2009 Jun; 27(5):561-7. PubMed ID: 19219653
[TBL] [Abstract][Full Text] [Related]
6. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
7. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
8. Full-term pregnancy induces a specific genomic signature in the human breast.
Russo J; Balogh GA; Russo IH
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):51-66. PubMed ID: 18199711
[TBL] [Abstract][Full Text] [Related]
9. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.
Poola I; DeWitty RL; Marshalleck JJ; Bhatnagar R; Abraham J; Leffall LD
Nat Med; 2005 May; 11(5):481-3. PubMed ID: 15864312
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy.
Bertucci F; Finetti P; Rougemont J; Charafe-Jauffret E; Nasser V; Loriod B; Camerlo J; Tagett R; Tarpin C; Houvenaeghel G; Nguyen C; Maraninchi D; Jacquemier J; Houlgatte R; Birnbaum D; Viens P
Cancer Res; 2004 Dec; 64(23):8558-65. PubMed ID: 15574762
[TBL] [Abstract][Full Text] [Related]
11. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
[TBL] [Abstract][Full Text] [Related]
12. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
Bertucci F; Viens P; Birnbaum D
Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of inflammatory breast cancer.
Bertucci F; Finetti P; Birnbaum D; Viens P
Cancer; 2010 Jun; 116(11 Suppl):2783-93. PubMed ID: 20503410
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.
Nguyen DM; Sam K; Tsimelzon A; Li X; Wong H; Mohsin S; Clark GM; Hilsenbeck SG; Elledge RM; Allred DC; O'Connell P; Chang JC
Clin Cancer Res; 2006 Sep; 12(17):5047-54. PubMed ID: 16951220
[TBL] [Abstract][Full Text] [Related]
15. Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trap.
Ferguson DA; Muenster MR; Zang Q; Spencer JA; Schageman JJ; Lian Y; Garner HR; Gaynor RB; Huff JW; Pertsemlidis A; Ashfaq R; Schorge J; Becerra C; Williams NS; Graff JM
Cancer Res; 2005 Sep; 65(18):8209-17. PubMed ID: 16166296
[TBL] [Abstract][Full Text] [Related]
16. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression profile in breast cancer-derived stromal fibroblasts.
Singer CF; Gschwantler-Kaulich D; Fink-Retter A; Haas C; Hudelist G; Czerwenka K; Kubista E
Breast Cancer Res Treat; 2008 Jul; 110(2):273-81. PubMed ID: 17899370
[TBL] [Abstract][Full Text] [Related]
18. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
Folgueira MA; Carraro DM; Brentani H; Patrão DF; Barbosa EM; Netto MM; Caldeira JR; Katayama ML; Soares FA; Oliveira CT; Reis LF; Kaiano JH; Camargo LP; Vêncio RZ; Snitcovsky IM; Makdissi FB; e Silva PJ; Góes JC; Brentani MM
Clin Cancer Res; 2005 Oct; 11(20):7434-43. PubMed ID: 16243817
[TBL] [Abstract][Full Text] [Related]
20. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]